Belvedere Trading LLC Summit Therapeutics Inc. Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$6.89 - $31.93 $16,536 - $76,632
-2,400 Reduced 9.38%
23,200 $508,000
Q2 2024

Nov 01, 2024
BUY
$2.39 - $10.92 $5,736 - $26,208
2,400 Added 10.34%
25,600 $199,000
Q2 2024

Aug 09, 2024
BUY
$2.39 - $10.92 $61,184 - $279,552
25,600 New
25,600 $199,000
Q3 2023

Oct 27, 2023
BUY
$1.54 - $2.42 $6,314 - $9,922
4,100 Added 1025.0%
4,500 $8,000
Q1 2023

May 15, 2023
BUY
$1.38 - $5.41 $552 - $2,164
400 New
400 $0

Others Institutions Holding SMMT

# of Institutions
193
Shares Held
75.8M
Call Options Held
2.01M
Put Options Held
2.84M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.82B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email